- Report
- February 2021
- 420 Pages
United States
From €2306EUR$2,400USD£1,980GBP
- Report
- September 2021
- 40 Pages
China
From €2498EUR$2,600USD£2,145GBP
- Report
- March 2019
- 17 Pages
Global
€9608EUR$10,000USD£8,248GBP
- Report
- March 2019
- 17 Pages
Global
€9608EUR$10,000USD£8,248GBP
- Report
- February 2024
- 89 Pages
Global
From €3500EUR$3,902USD£3,110GBP
Effexor (venlafaxine) is a medication used to treat mental disorders such as depression, anxiety, and panic disorder. It is a serotonin-norepinephrine reuptake inhibitor (SNRI) that works by increasing the levels of serotonin and norepinephrine in the brain. Effexor is available in both immediate-release and extended-release forms. It is usually taken once or twice daily with or without food. Common side effects include nausea, dry mouth, insomnia, and dizziness.
The Effexor market is a subset of the larger mental disorders drugs market. It is a competitive market with a variety of different medications available to treat mental disorders. Effexor is one of the most commonly prescribed medications for depression and anxiety.
Some companies in the Effexor market include Pfizer, GlaxoSmithKline, and Mylan. Show Less Read more